# Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation

> **NCT05908864** · — · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 123 (actual)

## Conditions studied

- Asthma Attack

## Interventions

- **DRUG:** Magnesium sulfate

## Key facts

- **NCT ID:** NCT05908864
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-11-22
- **Final completion:** 2020-12-15
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908864, "Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05908864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*